Cemiplimab is duly approved by the US FDA. Its key indication is cutaneous squamous cell carcinoma. It is also indicated in basal cell carcinoma and non-small cell lung cancer management. It is an advanced monoclonal antibody classified under immunotherapy medications. This is an innovative drug introduced by Regeneron Pharmaceuticals. Libtayo secured breakthrough therapy status by FDA. Libtayo 50mg vials are commercially accessible from the international markets. Cemiplimab price is determined based on the dosage recommendations and the subsequent quantity required for a patient. Libtayo price may be regulated in some parts of the world. However, the access is subject to its availability.
Libtayo 50mg/mL – Global approvals by US FDA & EU EMA
Regeneron and Sanofi promote Cemiplimab and are credited for their efforts in securing the important regulatory approvals. This first FDA approval was secured in 2018. It is now an approved medication for BCC, NSCLC and CSCC. The EMA approval was given to this drug in 2019. It was a conditional marketing approval or authorization. More evidence is expected from the ongoing clinical research in new indications.
- Libtayo is administered through IV route under the medical supervision. 350mg q3Weeks is the standard dosage for all the three noted indications. The medication is continued until tolerability issues or disease progression is observed.
- Incidentally, Cemiplimab is the first drug to be approved by the FDA more specifically advanced CSCC. It stands for cutaneous squamous cell carcinoma. The cost dynamics of this drug may be considered by the treating physicians before advising for its import in India.
Cemiplimab in India – Cost and access related information
Libtayo in India is prescribed by Medical Oncologists after duly considering the patient’s eligibility. It is natural for patients to search for Cemiplimab price in India. Before understanding the cost and related aspects, patients need to figure out the exact requirement in terms of the strength and quantity recommended. Cost of this medication is compared between European, US and Australian markets. Indian patients can import from whichever the country is economical for them.
Specialty medications including Cemiplimab in India (Libtayo) should be officially procured through authorized global distributors. These procedures and processes are standardized to a great extent. Considering the past experience of patients who imported lifesaving medicines, quite a few factors can impact the final cost. Foreign exchange or conversion rate could play an important role apart from the choice of logistics channels. Cemiplimab price could ultimately change based on the import or export specifications by the country at which the primary source is operating from. General awareness of these factors can help in more than many ways.
Cemiplimab in India – expert assistance for import
Libtayo is a specialized medication requiring special storage conditions. Constant temperate has to be maintained throughout the transit and shipment. Every company specifies the storage and shipment conditions that are ideal for every drug they manufacture. For Indian patients, CDSCO portal is the platform to procure the legal import permits. Patients can consider engaging experts who can make the entire experience of importing Libtayo in India hassle free. It may also be a wise thing to source and stock the medicines for the entire treatment. This helps in reducing the cost and gives patients the required peace of mind.
Contact Noel Biotech – +91 9677010046 / +91 992977766; email@example.com